Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 1;12(5):795-797.
doi: 10.21037/hbsn-23-335. Epub 2023 Sep 15.

Mucosa-associated microbiota alterations in primary sclerosing cholangitis (PSC) before and after liver transplantation-who is calling the shots?

Münevver Demir #  1 , Michael Sigal #  1   2
Affiliations
Editorial

Mucosa-associated microbiota alterations in primary sclerosing cholangitis (PSC) before and after liver transplantation-who is calling the shots?

Münevver Demir et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Klebsiella; Primary sclerosing cholangitis (PSC); liver transplantation; microbiota; mucosal microbiota.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-23-335/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Özdirik B, Müller T, Wree A, et al. The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies. Int J Mol Sci 2021;22:6975. 10.3390/ijms22136975 - DOI - PMC - PubMed
    1. Rühlemann M, Liwinski T, Heinsen FA, et al. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis. Aliment Pharmacol Ther 2019;50:580-9. 10.1111/apt.15375 - DOI - PMC - PubMed
    1. Demir M, Lang S, Hartmann P, et al. The fecal mycobiome in non-alcoholic fatty liver disease. J Hepatol 2022;76:788-99. 10.1016/j.jhep.2021.11.029 - DOI - PMC - PubMed
    1. Lang S, Demir M, Martin A, et al. Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology 2020;159:1839-52. 10.1053/j.gastro.2020.07.005 - DOI - PMC - PubMed
    1. Nakamoto N, Sasaki N, Aoki R, et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol 2019;4:492-503. 10.1038/s41564-018-0333-1 - DOI - PubMed